French public health and agricultural authorities have announced a global public health milestone: the first documented human infection with the Shamonda virus (Shav), a pathogen long known to circulate exclusively among livestock populations, has resulted in a patient death in early October.
Health officials have emphasized that the case is highly exceptional, occurring in a patient with severe immunocompromise that left their body far more susceptible to unusual pathogens than the general population. At this stage, there is no identified risk of widespread transmission or harm to the public, the agencies confirmed.
Prior to this event, Shav had never been recorded as causing human infection. The virus, which is primarily transmitted by the bite of infected midges, has for decades circulated among animal populations across Africa and Asia, with cattle being its most common host. Sporadic infections have also been documented in other farmed animals including sheep, goats, alpacas, and horses. Infected livestock typically develop symptoms including elevated body temperature, digestive distress such as diarrhea, and significant reductions in milk output for dairy herds.
Shav first reached European livestock in late July of this year, following its introduction to the continent. Since the initial detection, the virus has been identified in farm animal populations across multiple European nations, including Ireland, Germany, Italy, Spain, and the British Crown Dependency of Jersey. Local animal cases were first spotted in eastern France – the region where the infected patient is believed to have contracted the virus via midge bite – during the spring of 2020, French authorities confirmed in their Thursday briefing.
The patient, who was already undergoing treatment for a serious underlying health condition at a hospital in Lyon, developed severe neurological complications that initial investigations have found to be “very likely linked” to the novel Shamonda virus infection. The statement from French health and agriculture departments reiterated that the patient’s pre-existing weakened immune system was a critical factor in their vulnerability to this cross-species infection.
“Until now, the Shamonda virus was considered non-transmissible to humans,” the official statement noted, pointing out that no human cases had been recorded even after decades of the virus spreading among animal populations in Africa and Asia.
The European Centre for Disease Prevention and Control (ECDC) has confirmed it is actively monitoring the evolving situation, with ongoing investigations in partnership with French and other European public health agencies to trace how the virus made the jump from animal to human. The ECDC is also working to assess any potential long-term public health implications of this first recorded human infection. The case has already been formally reported to the World Health Organization as global health authorities prepare for any future developments related to the pathogen.